Jump to content
Sign in to follow this  

Canadian Convertible Debenture Market

Recommended Posts

...Keen on Mogo Finance / Important new upswing in place maybe

I sold half my Mogo Debs at $99, as the stock made a wild surge on a News release

MOGO... YTD: 6mo : 10d: / Last: 1.29 / Mogo.DB: 83.0-90.0




Date ET Symbol Price Type Headline
2020-07-16 07:15 C:MOGO 1.79 In the News Globe says Canccord's Taylor keen on Mogo Finance
2020-07-15 15:28 C:MOGO 1.24 News Release Mogo to release Q2 2020 results Aug. 11

The Globe and Mail reports in its Friday, July 17, edition that Canaccord Genuity analyst Doug Taylor raised his share target on Mogo Finance Technology to $4 from $3, citing better-than-expected second quarter results. The Globe's Darcy Keith writes in the Eye On Equities column that Mr. Taylor wrote about the jump in Mogo shares in the wake of the release of the company's preliminary second quarter financial results Thursday: "Beyond the strong financial performance in the quarter, we believe that the positive commentary around the performance of the loan book is driving this relief rally in the shares. We believe that, as credit concerns around the loan portfolio lift, investors will be able to focus on the growth opportunities ahead, including the roll-out of the MogoSpend product to its one-million-plus member base." Mr. Taylor continues to rate the shares "speculative buy." He believes "there is substantially more upside as the company builds out a track record of sustained cash flow profitability."


Mogo Inc. has provided a preliminary update on its financial results for the second quarter ended June 30, 2020.

Q2 2020 financial highlights

Mogo is expecting to report:

  • Revenue of $10.3 million to $10.5 million;
  • Adjusted EBITDA of $4.5 million to $5.0 million;
  • Positive operating cash flow net of investing activities of $6.5 million to $7.0 million.

Management Commentary

"Given the continued uncertainty caused by COVID-19, we believe it is important to provide a preview of our Q2 results, which demonstrate the resiliency of our financial model, the impact of our actions to create a leaner, more efficient cost structure and the levers in our business we can manage to significantly increase operating cash flow," said Greg Feller, President and CFO. "These steps helped drive a material and better-than-expected sequential improvement in net cash generated from operating and investing activities, as well as our highest-ever Adjusted EBITDA. Our loan portfolio continues to demonstrate resiliency in these challenging economic times. The record-low default rates we experienced in April and May, continued in June, giving us now several months of encouraging data on this diverse portfolio."

About Mogo

Mogo -- a financial technology company -- offers a finance app that empowers consumers with simple solutions to help them get in control of their financial wellness. Financial wellness continues to be the No. 1 source of stress across all demographics and highest among millennials. At Mogo, users can sign up for a free account in only three minutes and begin to learn the 4 habits of financial health and get convenient access to products that can help them achieve their financial goals. The Mogo platform has been purpose-built to deliver a best-in-class digital experience, with best-in-class products all through one account. With more than one million members and a marketing partnership with Canada's largest news media company, Mogo continues to execute on its vision of becoming the go-to financial app for the next generation of Canadians.

Share this post

Link to post
Share on other sites

FIRE.db / last: 27.95


Supreme Cannabis amends convertible debenture terms

2020-08-04 10:31 ET - News Release

Ms. Beena Goldenberg reports


The requisite majority holders of The Supreme Cannabis Company Inc.'s outstanding 6 per cent senior unsecured convertible debentures issued in October, 2018, have agreed to amend the terms of the debentures.

"We are pleased to have reached an agreement that significantly reduces the company's debt obligations and amends the debentures in advance of their original maturity in October, 2021," said Beena Goldenberg, president and chief executive officer of Supreme Cannabis. "This transaction offers holders of the debentures with an improved conversion rate that is aligned with current market conditions and affords our company additional flexibility and runway to accelerate revenue growth and achieve cost optimization as we continue on our path to near-term profitability."

The company has reduced the principal amount of the debentures by $63.5-million in exchange for the issuance of 116.6 million common shares, thereby converting debt to equity at a premium to the current share price. Holders of the debentures resident in eligible jurisdictions will receive one-half of the common shares as free-trading shares, and the other one-half of the common shares will be subject to a four-month restricted period. Holders of the debentures resident in other jurisdictions will be entitled to receive shares that are subject to restricted periods, subject to applicable securities laws.

The total principal amount of convertible debentures outstanding will be reduced from $100-million to $36.5-million, and the maturity date will be extended from Oct. 19, 2021, to Sept. 1, 2025, unless repurchased, redeemed or converted prior to maturity. The remaining debentures will accrete at a rate of 11.06 per cent per year, compounding on a semi-annual basis, commencing on Sept. 1, 2020, and ending on Sept. 1, 2023. The accreted portion of the principal is payable in cash, but does not bear cash interest and is not convertible into the company's common shares. The accreted portion of the principal will be evidenced by a separate series of debentures, which will not be listed on the Toronto Stock Exchange.

The conversion price of the remaining convertible debentures outstanding will be reduced from $2.45 per share to 28.5 cents per share, and annual interest payments will be reduced to $2.9-million from $6-million. The company will have the right to force the conversion of the remaining principal amount of the convertible debentures outstanding at the conversion price on no less than 30 days of notice if the daily volume-weighted average trading price of the company's common shares is greater than 45 cents for any 10 consecutive trading days. The principal amount of the remaining debentures will amortize at 1 per cent per month over the 24 months prior to maturity.

Share this post

Link to post
Share on other sites

ChemTrade Logistics.    : O/S Prin.: Conver.: Price  :  Last Price : Yield : YTM

> / CHE.un: 92.6M units. : $ 450M  : - N/A - :  $4.86  : $4.85 - 4.86 : 12.3%: BV $7.66
B / 5.25% : 30 Jun., 2021: $ 14.5M*: $28.00: 100.35 : 100.2-100.5 : 5.23%:
C / 5.00% : 31 Aug., 2023: $143.8M: $24.85: $82.25: 82.00-82.50 : 6.08%:
D / 4.75% : 31 May, 2024: $201.1M: $26.70: $75.00: 73.00-77.00 : 6.33%:
E / 6.50% : 31 Oct., 2026: $100.0M: $15.80: $73.00: 72.00-73.90 : 8.90%:
F / 8.50%  : 30 Sep. 2025: $ 86.3M: $   7.35: $93.40: 93.00-93.79 : 9.10%:
======== : ====== Total: $545.5M:
> Update : https://www.stockwatch.com/Quote/Detail?C:CHE.UT

*redeemed $100M, 9-29, and $12.5M on Oct 5th, leaving just $14.5M

Share this post

Link to post
Share on other sites

IVQ / Invesque Inc. ... update:  Last: C$1.65



T:IVQ.DB.V - INVESQUE INC 6.00 PCT DEBS USD > can be redeemed w/shares values at 95%

   IVQ.DB.V - T   40.0 81.00 · 82.75 39.0 81.00

T:IVQ.DB.U - INVESQUE INC 5.00 PCT DEBS USD  (raised to 7%??)

   IVQ.DB.U - T     3.0 67.01 · 74.00 11.0 75.00


On November 15, 2021, a meeting of holders of the 2016 Convertible Debentures was held whereby the holders of
2016 Convertible Debentures ("2016 Debentureholders") approved proposed amendments to the 2016 Convertible
Debentures. The approved amendments include the following changes to the 2016 Convertible Debentures:

1. Increase the interest rate from 5.00% to 7.00%, effective January 31, 2022.
2. Decrease the conversion price from $11.00 to $5.00 per share.
3. Extension of the maturity date from January 31, 2022 to January 31, 2025.
4. Approval of the redemption of $20,000 of the principal amount of the 2016 Co..

2018 Convertible Debentures
On August 24, 2018, the Company issued $50,000 aggregate principal amount of convertible unsecured subordinated
debentures (the "2018 Convertible Debentures"). The 2018 Convertible Debentures are due on September 30, 2023
and bear interest at an annual rate of 6.00% payable semi-annually in arrears on March 31 and September 30 of each
year commencing on March 31, 2019.

The 2018 Convertible Debentures are convertible into common shares of the Company at the option of the holder at a
conversion price of $10.70 per common share. The debentures will not be redeemable prior to September 30, 2021.
(delete?: On or after September 30, 2021, and prior to September 30, 2022, the 2018 Convertible Debentures may be redeemed
in whole or in part from time to time at the Company’s option, at a price equal to their principal amount plus accrued
and unpaid interest, provided that the volume weighted average trading price of the common shares on the Toronto
Stock Exchange for the 20 consecutive trading days preceding the date on which the notice of redemption is given is
not less than 125% of the conversion price.) On or after September 30, 2022, and prior to the maturity date, the 2018
Convertible Debentures may be redeemed by the Company, in whole at any time or in part from time to time, at a
price equal to the principal amount thereof plus accrued and unpaid interest.

Upon redemption or maturity, the Company may satisfy its obligations with respect to the convertible debentures in
cash or the issuance of common shares based on 95% of the Current Market Price...

Share this post

Link to post
Share on other sites
Invesque Inc
Symbol IVQ
Shares Issued 55,164,658. / Mkt Cap: C$ 87.15M.   at
Close 2022-07-28 C$ 1.58.       / Range:

IVQ.DB.V - T  

11.0 88.75 · 94.00 53.0 89.00 +3.00 3.5 149.0 133

T:IVQ.DB.V - INVESQUE INC. 6% DEB USF ... update -  (Note: 20K Face)


IVQ.t / Invesque Inc ... 3yr: C$ 1.58


Invesque sells $113-million (U.S.) of non-core assets

2022-07-28 19:13 ET - News Release

Mr. Scott White reports


Invesque Inc. has sold $113-million (U.S.) of non-core assets. Inclusive of previously announced dispositions, the company has sold $292-million (U.S.) of assets over the last 12 months.

On June 15, 2022, Invesque closed on the sale of its interests in two 55-plus communities in Wheatfield, N.Y.

  • The communities were acquired in 2018 as part of the acquisition of Care Investment Trust and were managed by Calamar under a joint venture structure.
  • The implied pricing from the sale transaction was very favourable with an implied price per unit of $145,000 (U.S.) and an implied cap rate of 5.7 per cent on trailing NOI (net operating income).
  • The two Calamar communities operate as age-restricted apartment complexes and feature substantially less resident and health care services than traditional seniors housing owned by Invesque.
  • The company received net cash proceeds of $10.0-million (U.S.) at closing and plans to utilize proceeds to continue delevering and simplifying its balance sheet.

On July 26, 2022, the company closed on the sale of the University Boulevard medical office building in Orlando, Fla., for $9.85-million (U.S.).

  • This stand-alone transaction was consummated with the operator of the surgery centre that is the largest tenant at the property.
  • The sale price reflected the high quality of the underlying real estate equal to nearly $300 (U.S.) per rentable square foot and a cap rate of 7.2 per cent on trailing NOI.

On July 28, 2022, the company closed on the sale of nine medical office buildings in Canada for $94.3-million.

. . . Following the completion of these transactions, the company's PORTFOLIO consists of 83 properties with approximately 5,700 units, 7,800 beds and 190,000 square feet of medical office buildings across 18 states and one Canadian province.

BMO Capital Markets acted as financial adviser to Invesque in connection with the sale of the Canadian medical office properties.

About Invesque Inc.

Invesque is a North American health care real estate company with an investment thesis focused on the premise that an aging demographic in North America will continue to utilize health care services in growing proportion to the overall economy. Invesque currently capitalizes on this opportunity by investing in a portfolio of income generating properties across the health care spectrum. Invesque's portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care and medical office properties, which are operated under long-term leases and joint venture arrangements with industry leading operating partners. Invesque's portfolio also includes investments in owner-occupied seniors housing properties, in which Invesque owns the real estate and provides management services through its subsidiary management company, Commonwealth Senior Living.

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this